Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2007 4
2008 1
2009 2
2010 9
2011 5
2012 10
2013 7
2014 6
2015 8
2016 6
2017 3
2018 9
2019 8
2020 8
2021 5
2022 8
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer.
Kaidar-Person O, Vrou Offersen B, Hol S, Arenas M, Aristei C, Bourgier C, Cardoso MJ, Chua B, Coles CE, Engberg Damsgaard T, Gabrys D, Jagsi R, Jimenez R, Kirby AM, Kirkove C, Kirova Y, Kouloulias V, Marinko T, Meattini I, Mjaaland I, Nader Marta G, Witt Nystrom P, Senkus E, Skyttä T, Tvedskov TF, Verhoeven K, Poortmans P. Kaidar-Person O, et al. Among authors: bourgier c. Radiother Oncol. 2019 Aug;137:159-166. doi: 10.1016/j.radonc.2019.04.010. Epub 2019 May 17. Radiother Oncol. 2019. PMID: 31108277
[Partial breast irradiation].
Bourgier C, Lemanski C, Fenoglietto P, Riou O, Dubois JB, Azria D. Bourgier C, et al. Bull Cancer. 2014 Jan 1;101(1):52-5. doi: 10.1684/bdc.2013.1869. Bull Cancer. 2014. PMID: 24445657 Review. French.
Management of the Axilla in the Era of Breast Cancer Heterogeneity.
de Meric de Bellefon M, Lemanski C, Ducteil A, Fenoglietto P, Azria D, Bourgier C. de Meric de Bellefon M, et al. Among authors: bourgier c. Front Oncol. 2018 Apr 4;8:84. doi: 10.3389/fonc.2018.00084. eCollection 2018. Front Oncol. 2018. PMID: 29670853 Free PMC article. Review.
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer.
Jandu HK, Veal CD, Fachal L, Luccarini C, Aguado-Barrera ME, Altabas M, Azria D, Baten A, Bourgier C, Bultijnck R, Colciago RR, Farcy-Jacquet MP, Chang-Claude J, Choudhury A, Dunning A, Elliott RM, Green S, Gutiérrez-Enríquez S, Herskind C, Lambrecht M, Monten C, Rancati T, Reyes V, Rosenstein BS, De Ruysscher D, Carmen De Santis M, Seibold P, Sperk E, Veldwijk M, Paul Symonds R, Stobart H, Taboada-Valladares B, Vega A, Veldeman L, Webb AJ, Weltens C, West CM, Rattay T, Talbot CJ; REQUITE consortium. Jandu HK, et al. Among authors: bourgier c. Radiother Oncol. 2023 Oct;187:109806. doi: 10.1016/j.radonc.2023.109806. Epub 2023 Jul 10. Radiother Oncol. 2023. PMID: 37437607 Free article.
T lymphocytes to predict radiation-induced late effects in normal tissues.
Brengues M, Lapierre A, Bourgier C, Pèlegrin A, Özsahin M, Azria D. Brengues M, et al. Among authors: bourgier c. Expert Rev Mol Diagn. 2017 Feb;17(2):119-127. doi: 10.1080/14737159.2017.1271715. Epub 2016 Dec 22. Expert Rev Mol Diagn. 2017. PMID: 27936985 Review.
Genomic classifications and radiotherapy for breast cancer.
Britten A, Rossier C, Taright N, Ezra P, Bourgier C. Britten A, et al. Among authors: bourgier c. Eur J Pharmacol. 2013 Oct 5;717(1-3):67-70. doi: 10.1016/j.ejphar.2012.11.069. Epub 2013 Apr 9. Eur J Pharmacol. 2013. PMID: 23583322 Review.
[Breast cancer: radiotherapy and estrogen signaling].
Bourgier C, Lemanski C, Romieu G, Ozsahin M, Azria D. Bourgier C, et al. Bull Cancer. 2014 Jul-Aug;101(7-8):714-7. doi: 10.1684/bdc.2014.1954. Bull Cancer. 2014. PMID: 25091654 Review. French.
99 results